DR. VIVIAN CLINE MD NPI 1003870759

NPI Details

DR. Vivian Cline, MD is a medical oncology internal medicine in Round Rock, TX with 30 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Vivian Cline, MD NPI is 1003870759. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

301 SETON PKWY
SUITE 104
ROUND ROCK, TX
ZIP 78665-002
Phone: (512) 687-2300
Fax: (512) 687-2350

The NPI 1003870759 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Iron level (HCPCS:83540)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Iron binding capacity (HCPCS:83550)
• Vitamin d-3 level (HCPCS:82306)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Ferritin (blood protein) level (HCPCS:82728)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Unclassified drugs (HCPCS:J3490)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (HCPCS:86320)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Red blood count, automated test (HCPCS:85045)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Folic acid level, serum (HCPCS:82746)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Drawing of blood for a medical problem (HCPCS:99195)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)

The enumeration date for this NPI number is 4/12/2006 and was last updated on 7/14/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.